EV 기반 액체 생검 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제공 형태별, 워크플로우별, 기술별, 검체 유형별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
EV-Based Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering, By Workflow, By Technology, By Sample Type, By End user, By Region and Competition, 2020-2030F
상품코드:1878856
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 세포외소포(EV) 기반 액체 생검 시장은 2024년에 9,112만 달러로 평가되었으며, 2030년까지 CAGR 9.74%로 성장하여 1억 5,914만 달러에 달할 것으로 예측됩니다.
세포외소포(EV) 기반 액체 생검은 혈액, 소변 등 체액 속에 순환하는 엑소좀 등 세포외소포 내에 포함된 질병 특이적 바이오마커를 비침습적으로 분석하는 방법입니다. 이들 소포는 단백질, 핵산, 지질 등의 분자 물질을 운반하며, 유래 세포의 생리적, 병리적 상태에 대한 지식을 제공합니다. 시장 확대는 특히 암을 비롯한 만성질환의 전 세계적 부담 증가와 조기 비침습적 진단 솔루션에 대한 수요 증가로 인해 크게 촉진되고 있습니다. 생체액 내 EV의 고유한 안정성과 풍부함은 다른 순환 바이오마커에 비해 우위를 제공하며, 주요 성장 촉진요인으로 작용하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
9,112만 달러
시장 규모 : 2030년
1억 5,914만 달러
CAGR : 2025-2030년
9.74%
가장 빠르게 성장하는 부문
키트 및 어세이
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 EV 기반 액체 생검 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제공 형태별(키트·어세이, 서비스, 기기)
워크플로우별(샘플 조제, 시퀀싱, 데이터 분석)
기술별(분리 기술, 분석 기술)
샘플 유형별(혈액, 소변, 타액, 기타)
최종사용자별(학술연구기관, 제약·바이오테크놀러지 기업, 임상 검사실)
지역별
기업별(2024)
시장 맵
제6장 북미의 EV 기반 액체 생검 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 EV 기반 액체 생검 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 EV 기반 액체 생검 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 EV 기반 액체 생검 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 EV 기반 액체 생검 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 EV 기반 액체 생검 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Horiba Ltd.
Thermo Fisher Scientific, Inc.
Lonza Group AG
Takara Bio Inc.
Abcam plc
Qiagen N.V.
Malvern Panalytical Ltd.
Revvity, Inc.(PerkinElmer, Inc)
Norgen Biotek Corp.
Bio-Techne Corporation
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global EV-Based Liquid Biopsy Market , valued at USD 91.12 Million in 2024, is projected to experience a CAGR of 9.74% to reach USD 159.14 Million by 2030. Extracellular vesicle (EV)-based liquid biopsy involves the non-invasive analysis of disease-specific biomarkers encapsulated within extracellular vesicles, such as exosomes, circulating in bodily fluids like blood or urine. These vesicles carry molecular cargoes including proteins, nucleic acids, and lipids, providing insights into the physiological and pathological state of originating cells. The market's expansion is significantly driven by the increasing global burden of chronic diseases, particularly cancer, and the rising demand for early, non-invasive diagnostic solutions. The inherent stability and abundance of EVs in biofluids, offering advantages over other circulating biomarkers, also act as key growth facilitators.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 91.12 Million
Market Size 2030
USD 159.14 Million
CAGR 2025-2030
9.74%
Fastest Growing Segment
Kits & Assays
Largest Market
North America
Key Market Drivers
The escalating global cancer burden fundamentally drives the EV-based liquid biopsy market. Traditional diagnostic methods often face limitations in early detection and continuous monitoring, areas where the non-invasive nature of EV liquid biopsies offers significant advantages. As cancer incidence continues its upward trajectory, the urgency for advanced, accessible diagnostic tools intensifies. According to the International Agency for Research on Cancer (IARC), in 2022, there were close to 20 million new cases of cancer worldwide. This pervasive health crisis necessitates innovative solutions that can accurately identify malignancies at earlier stages and monitor treatment efficacy without the invasiveness of tissue biopsies, directly propelling the adoption and development of EV-based platforms.
Key Market Challenges
A substantial challenge impeding the growth of the Global EV-Based Liquid Biopsy Market is the ongoing technical complexity associated with isolating and comprehensively characterizing extracellular vesicles (EVs) from complex biofluids. This inherent variability in isolation methods and subsequent characterization protocols often leads to significant issues with reproducibility and consistent clinical validation. The lack of standardized procedures across different laboratories and platforms directly compromises the reliability of test results, creating skepticism among clinicians and delaying the widespread adoption of EV-based diagnostic solutions.
Key Market Trends
The emergence of novel EV biomarkers is significantly shaping the global EV-based liquid biopsy market by enhancing diagnostic precision and expanding application areas. Research into disease-specific cargo within extracellular vesicles, such as proteins and nucleic acids, is uncovering new targets for early detection and disease monitoring across various pathologies. This focus on biomarker discovery drives the development of more sensitive and specific diagnostic assays. According to the International Society for Extracellular Vesicles, its MISEV2023 guidelines, published in March 2024, garnered consensus from approximately 97% of surveyed members, reflecting a widespread scientific commitment to standardizing and advancing EV research which underpins biomarker identification. This collective effort is crucial for translating promising biomarker candidates into validated clinical tools. Furthermore, a review article in *Biology (Basel)* in September 2024, highlighted the therapeutic opportunity of tumor-derived extracellular vesicles, emphasizing their capacity to harbor cancer-derived cargo reflective of their cell-of-origin and their superior stability in blood for diagnostic and prognostic insights.
Key Market Players
Horiba Ltd.
Thermo Fisher Scientific, Inc.
Lonza Group AG
Takara Bio Inc.
Abcam plc
Qiagen N.V.
Malvern Panalytical Ltd.
Revvity, Inc. (PerkinElmer, Inc)
Norgen Biotek Corp.
Bio-Techne Corporation
Report Scope:
In this report, the Global EV-Based Liquid Biopsy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
EV-Based Liquid Biopsy Market , By Offering:
Kits & Assays
Services
Instruments
EV-Based Liquid Biopsy Market , By Workflow:
Sample Preparation
Sequencing
Data Analysis
EV-Based Liquid Biopsy Market , By Technology:
Isolation Technologies
Analysis Technologies
EV-Based Liquid Biopsy Market , By Sample Type:
Blood
Urine
Saliva
Others
EV-Based Liquid Biopsy Market , By End User:
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Clinical Laboratories
EV-Based Liquid Biopsy Market , By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global EV-Based Liquid Biopsy Market .
Available Customizations:
Global EV-Based Liquid Biopsy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global EV-Based Liquid Biopsy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Offering (Kits & Assays, Services, Instruments)
5.2.2. By Workflow (Sample Preparation, Sequencing, Data Analysis)
5.2.3. By Technology (Isolation Technologies, Analysis Technologies)
5.2.4. By Sample Type (Blood, Urine, Saliva, Others)
5.2.5. By End User (Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Laboratories)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America EV-Based Liquid Biopsy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Offering
6.2.2. By Workflow
6.2.3. By Technology
6.2.4. By Sample Type
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States EV-Based Liquid Biopsy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Offering
6.3.1.2.2. By Workflow
6.3.1.2.3. By Technology
6.3.1.2.4. By Sample Type
6.3.1.2.5. By End User
6.3.2. Canada EV-Based Liquid Biopsy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Offering
6.3.2.2.2. By Workflow
6.3.2.2.3. By Technology
6.3.2.2.4. By Sample Type
6.3.2.2.5. By End User
6.3.3. Mexico EV-Based Liquid Biopsy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Offering
6.3.3.2.2. By Workflow
6.3.3.2.3. By Technology
6.3.3.2.4. By Sample Type
6.3.3.2.5. By End User
7. Europe EV-Based Liquid Biopsy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Offering
7.2.2. By Workflow
7.2.3. By Technology
7.2.4. By Sample Type
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany EV-Based Liquid Biopsy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Offering
7.3.1.2.2. By Workflow
7.3.1.2.3. By Technology
7.3.1.2.4. By Sample Type
7.3.1.2.5. By End User
7.3.2. France EV-Based Liquid Biopsy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Offering
7.3.2.2.2. By Workflow
7.3.2.2.3. By Technology
7.3.2.2.4. By Sample Type
7.3.2.2.5. By End User
7.3.3. United Kingdom EV-Based Liquid Biopsy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Offering
7.3.3.2.2. By Workflow
7.3.3.2.3. By Technology
7.3.3.2.4. By Sample Type
7.3.3.2.5. By End User
7.3.4. Italy EV-Based Liquid Biopsy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Offering
7.3.4.2.2. By Workflow
7.3.4.2.3. By Technology
7.3.4.2.4. By Sample Type
7.3.4.2.5. By End User
7.3.5. Spain EV-Based Liquid Biopsy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Offering
7.3.5.2.2. By Workflow
7.3.5.2.3. By Technology
7.3.5.2.4. By Sample Type
7.3.5.2.5. By End User
8. Asia Pacific EV-Based Liquid Biopsy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Offering
8.2.2. By Workflow
8.2.3. By Technology
8.2.4. By Sample Type
8.2.5. By End User
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China EV-Based Liquid Biopsy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Offering
8.3.1.2.2. By Workflow
8.3.1.2.3. By Technology
8.3.1.2.4. By Sample Type
8.3.1.2.5. By End User
8.3.2. India EV-Based Liquid Biopsy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Offering
8.3.2.2.2. By Workflow
8.3.2.2.3. By Technology
8.3.2.2.4. By Sample Type
8.3.2.2.5. By End User
8.3.3. Japan EV-Based Liquid Biopsy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Offering
8.3.3.2.2. By Workflow
8.3.3.2.3. By Technology
8.3.3.2.4. By Sample Type
8.3.3.2.5. By End User
8.3.4. South Korea EV-Based Liquid Biopsy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Offering
8.3.4.2.2. By Workflow
8.3.4.2.3. By Technology
8.3.4.2.4. By Sample Type
8.3.4.2.5. By End User
8.3.5. Australia EV-Based Liquid Biopsy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Offering
8.3.5.2.2. By Workflow
8.3.5.2.3. By Technology
8.3.5.2.4. By Sample Type
8.3.5.2.5. By End User
9. Middle East & Africa EV-Based Liquid Biopsy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Offering
9.2.2. By Workflow
9.2.3. By Technology
9.2.4. By Sample Type
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia EV-Based Liquid Biopsy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Offering
9.3.1.2.2. By Workflow
9.3.1.2.3. By Technology
9.3.1.2.4. By Sample Type
9.3.1.2.5. By End User
9.3.2. UAE EV-Based Liquid Biopsy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Offering
9.3.2.2.2. By Workflow
9.3.2.2.3. By Technology
9.3.2.2.4. By Sample Type
9.3.2.2.5. By End User
9.3.3. South Africa EV-Based Liquid Biopsy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Offering
9.3.3.2.2. By Workflow
9.3.3.2.3. By Technology
9.3.3.2.4. By Sample Type
9.3.3.2.5. By End User
10. South America EV-Based Liquid Biopsy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Offering
10.2.2. By Workflow
10.2.3. By Technology
10.2.4. By Sample Type
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil EV-Based Liquid Biopsy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Offering
10.3.1.2.2. By Workflow
10.3.1.2.3. By Technology
10.3.1.2.4. By Sample Type
10.3.1.2.5. By End User
10.3.2. Colombia EV-Based Liquid Biopsy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Offering
10.3.2.2.2. By Workflow
10.3.2.2.3. By Technology
10.3.2.2.4. By Sample Type
10.3.2.2.5. By End User
10.3.3. Argentina EV-Based Liquid Biopsy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Offering
10.3.3.2.2. By Workflow
10.3.3.2.3. By Technology
10.3.3.2.4. By Sample Type
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global EV-Based Liquid Biopsy Market : SWOT Analysis
